As CIN fuels karyotypic heterogeneity during tumor cell evolution, CIN will likely promote selection of karyotypes that promote activity of pro-tumorigenic non-canonical NF-κB and STAT3 signaling and inhibit tumor-suppressive STAT1 signaling programs. Here, NFKB1 is linked to neoplasm.